Physician profile
David Powell
NPI 1720084957
$610.29
in general payments reported to CMS, 2019-2025
8 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $115 · 2021: $11.92 · 2022: $72.96 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150 · Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
| Food and Beverage | $137.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $199.90 | 2019-2020 | |
| Array Biopharma INC | $150.00 | 2025 | Braftovi, Lorbrena, Mektovi |
| Daiichi Sankyo INC. | $137.75 | 2025 | Enhertu, Datroway |
| Seagen INC. | $52.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.84 | 2020-2022 | |
| Gilead Sciences, INC. | $11.92 | 2021 | |
| Pfizer INC. | $11.50 | 2019 | |
| Puma Biotechnology, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.